CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
COMPASS Pathways plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$11.11+0.36 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $1.50B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
COMPASS Pathways has not reported a dividend
No dividend per share appears in COMPASS Pathways's annual filings since fiscal 2018.